The MedCan 2022 Industry Summit will help local companies accelerate their path to market through valuable insights into exporting, innovation and education. Industry experts will be presenting the latest scientific findings and breakthrough technologies and exploring the current challenges and opportunities around the likes of cultivating, manufacturing, New Zealand regulations, export, clinical trials, prescription and investment.
Day 1 – Industry Summit – 10 February
08:20
Industry Stream Stream Online
08:40
Industry Stream BioTech NZ’s welcome to the MedCan Summit 2022 Dr Zahra Champion Executive Director, BioTechNZ
Dr Zahra Champion Executive Director, BioTechNZ
Industry Stream Mihi/Karakia
08:50
Industry Stream Opening remarks from the MC Andrew Patterson Business Commentator
Andrew Patterson Business Commentator
09:05
Industry Stream BioTechNZ’s welcome to the MedCan Summit Dr Zahra Champion Executive Director, BioTechNZ
Dr Zahra Champion Executive Director, BioTechNZ
09:10
Industry Stream Networking breakout spacesMeet and greet your fellow attendees in random breakout rooms in this icebreaker session.
Meet and greet your fellow attendees in random breakout rooms in this icebreaker session.
09:20
Industry Stream Opening keynote: Global sector review | How is the medicinal cannabis industry shaping globally? Melissa Clark-Reynolds Futurist, futurecentre.nz - Looking into how cannabinoids are being used across sector i.e. cosmetics, beverages and more
- Insights into evidence on consumption trends across the globe
- What impact is medicinal cannabis having?
- How is this driving product design in the industry?
Melissa Clark-Reynolds Futurist, futurecentre.nz
- Looking into how cannabinoids are being used across sector i.e. cosmetics, beverages and more
- Insights into evidence on consumption trends across the globe
- What impact is medicinal cannabis having?
- How is this driving product design in the industry?
09:50
Industry Stream Ministerial Address Hon. Andrew Little Minister of Health, Labour Party
Hon. Andrew Little Minister of Health, Labour Party
10:05
Industry Stream CEO panel: The state of play for New Zealand’s medicinal cannabis industry in 2022 and beyond Carmen Doran Chief Executive Officer, Helius Therapeutics Mark Lucas Chief Executive Officer, Cannasouth Tim Aldridge Managing Director, Puro Mitch Cuevas Pharmaceutical Director, Eqalis - Comparing New Zealand’s medicinal cannabis industry to the world
- The opportunity to join the global industry and be amongst the global players
- What is unique about New Zealand’s harvest (and product) to drive a global opportunity to drive our economy as well as contribute to global healthcare and wellbeing outcomes?
- What are the milestones that the industry needs to reach to achieve a commercially sustainable industry?
- Keeping it local – what are the collaboration options for Maori businesses and organisations to expand their interest in primary industries?
Manu Caddie, Co-Founder, Kaihautu – Innovation and Regulation, Rua Bioscience
Carmen Doran Chief Executive Officer, Helius Therapeutics
Mark Lucas Chief Executive Officer, Cannasouth
Tim Aldridge Managing Director, Puro
Mitch Cuevas Pharmaceutical Director, Eqalis
- Comparing New Zealand’s medicinal cannabis industry to the world
- The opportunity to join the global industry and be amongst the global players
- What is unique about New Zealand’s harvest (and product) to drive a global opportunity to drive our economy as well as contribute to global healthcare and wellbeing outcomes?
- What are the milestones that the industry needs to reach to achieve a commercially sustainable industry?
- Keeping it local – what are the collaboration options for Maori businesses and organisations to expand their interest in primary industries?
Manu Caddie, Co-Founder, Kaihautu – Innovation and Regulation, Rua Bioscience
11:00
Industry Stream BREAK
11:15
Science Stream Science stream MC Imche Fourie Co-Founder & CEO, Outset Ventures
Imche Fourie Co-Founder & CEO, Outset Ventures
Industry Stream Industry stream MC Andrew Patterson Business Commentator
Andrew Patterson Business Commentator
11:20
Industry Stream Panel: Women in the medicinal cannabis industry Carmen Doran Chief Executive Officer, Helius Therapeutics Eva Neshat Founder and Chief Executive Officer, Elysian Pharmaceuticals & CannaPlus+ Zoë Reece Founder and CEO, Ora Pharm Dr Dottie Clower Chief Scientific Officer, Puro
Carmen Doran Chief Executive Officer, Helius Therapeutics
Eva Neshat Founder and Chief Executive Officer, Elysian Pharmaceuticals & CannaPlus+
Zoë Reece Founder and CEO, Ora Pharm
Dr Dottie Clower Chief Scientific Officer, Puro
Science Stream Digging for seeds | Opportunities to run an internationally competitive structured breeding programme for New Zealand Dr Anna Campbell Consultant, AbacusBio • New Zealand gene bank
• different genetic technologies
• development of unique plants to those grown internationally
• Which traits to select- from disease resistance to cannabinoid profiles
• role of data management in a well-run breeding programme
Dr Anna Campbell Consultant, AbacusBio
• New Zealand gene bank
• different genetic technologies
• development of unique plants to those grown internationally
• Which traits to select- from disease resistance to cannabinoid profiles
• role of data management in a well-run breeding programme
11:50
Science Stream Understand the diseases that threaten NZ’s medicinal cannabis industry Kai Keli’iho’omalu Cultivation Manager, Helius Therapeutics
Kai Keli’iho’omalu Cultivation Manager, Helius Therapeutics
12:20
Industry Stream Investing in the future of the medical cannabis industry Kristen Lunman Co-Founder and GM, Hatch • Types of investment
• Trends
• Future of investments
Kristen Lunman Co-Founder and GM, Hatch
• Types of investment
• Trends
• Future of investments
Science Stream Fireside chat: Helping talent navigate through the sector Carmen Doran Chief Executive Officer, Helius Therapeutics Ali Seyfoddin Associate Professor of Drug Delivery and Biological Engineering Deputy Head of School, School of Science, Auckland University of Technology
Carmen Doran Chief Executive Officer, Helius Therapeutics
Ali Seyfoddin Associate Professor of Drug Delivery and Biological Engineering Deputy Head of School, School of Science, Auckland University of Technology
12:50
Industry Stream Sustainable sector development through ‘whole plant’ utilisation Andrew Cameron Principal Consultant, Callaghan Innovation Anna Yallop General Manager, Bioresource Processing Alliance This presentation will highlight the commercial potential for medicinal cannabis or hemp beyond its primary use by taking a ‘whole of resource’ approach. It will outline how the Bioresource Processing Alliance and research providers can help industry partners identify high-value opportunities from low-value biological resources.
Andrew Cameron Principal Consultant, Callaghan Innovation
Anna Yallop General Manager, Bioresource Processing Alliance
This presentation will highlight the commercial potential for medicinal cannabis or hemp beyond its primary use by taking a ‘whole of resource’ approach. It will outline how the Bioresource Processing Alliance and research providers can help industry partners identify high-value opportunities from low-value biological resources.
Science Stream Fireside chat: Insights from the study on COVID for the MedCan industry Dr. Adele Hosseini, PhD Chief Scientific Officer, Bod Australia
Dr. Adele Hosseini, PhD Chief Scientific Officer, Bod Australia
13:20
Industry Stream Networking Breakouts
13:40
Industry Stream LUNCH BREAK
14:10
Industry Stream Ministry of Health Address: Medicinal Cannabis Scheme | An update on New Zealand’s current roadblocks and Opportunities Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health - Medicinal cannabis licensing regime
- Verification of products against the minimum quality standards
- Regulation changes
Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
- Medicinal cannabis licensing regime
- Verification of products against the minimum quality standards
- Regulation changes
14:40
Industry Stream Closing keynote: An agronomic approach to the cultivation of medicinal cannabis Tom Forrest Cultivation Director, Puro - Providing an overview of AUS/NZ approach to growing cannabis for medicinal purposes
- An in-depth discussion on indoor versus outdoor growth – how do they differ and will one dominate over the other?
- Showcasing technology in play to capture data and assisting with cultivation
- The road that lays ahead – opportunities for growth and collaboration
Tom Forrest Cultivation Director, Puro
- Providing an overview of AUS/NZ approach to growing cannabis for medicinal purposes
- An in-depth discussion on indoor versus outdoor growth – how do they differ and will one dominate over the other?
- Showcasing technology in play to capture data and assisting with cultivation
- The road that lays ahead – opportunities for growth and collaboration
15:20
Industry Stream Summary remarks from the Chair
Day 2 – Industry Summit – 11 February
08:30
Plenary Stream Online
09:20
Plenary Fireside chat Bonni Goldstein Medical Director, Canna Centers Wellness & Education
Bonni Goldstein Medical Director, Canna Centers Wellness & Education
09:40
Plenary MP Address Brooke van Velden List Member, ACT Party
Brooke van Velden List Member, ACT Party
10:40
Plenary Morning break
12:30
Plenary Lunch Break
13:00
Plenary Roundtables: Delegates have the opportunity to participate in roundtables facilitated by subject matter experts on specific themes. Delegates can attend x2 sessions and the topics to choose from are:- Application process in obtaining a licence through the Medicinal Cannabis Agency – tips and tricks
Facilitator: Andrea Eng, Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health - EBM4CBD/THC
Facilitators: Dr Michael Murphy MB, BS, Pharm B.Sc (Hons), Clinical Director, CannaPlus+;
Dr Afraz Adam MBBS. FRNZCUC, Chief Medical Officer, CannaPlus+
Extraction technologies
Steve Tallon Team Leader, Process Engineering Group, Callaghan Innovation - Analysis and testing
Facilitators: Bruce Fraser, New Zealand General Manager, Shimadzu
Sam Dallas, Analytical Technology Technician, Hill Laboratories
- Application process in obtaining a licence through the Medicinal Cannabis Agency – tips and tricks
Facilitator: Andrea Eng, Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health - EBM4CBD/THC
Facilitators: Dr Michael Murphy MB, BS, Pharm B.Sc (Hons), Clinical Director, CannaPlus+;
Dr Afraz Adam MBBS. FRNZCUC, Chief Medical Officer, CannaPlus+
Extraction technologies
Steve Tallon Team Leader, Process Engineering Group, Callaghan Innovation - Analysis and testing
Facilitators: Bruce Fraser, New Zealand General Manager, Shimadzu
Sam Dallas, Analytical Technology Technician, Hill Laboratories
13:00
Roundtables Session 1: Application process in obtaining a licence through the Medicinal Cannabis Agency – tips and tricks Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
13:00
Roundtables Session 1: EBM4CBD/THC Dr Michael Murphy Clinical Director, CannaPlus+ Dr Afraz Adam MBBS. FRNZCUC Chief Medical Officer, CannaPlus+
Dr Michael Murphy Clinical Director, CannaPlus+
Dr Afraz Adam MBBS. FRNZCUC Chief Medical Officer, CannaPlus+
13:00
Roundtables Session 1: Extraction technologies Steve Tallon Team Leader, Process Engineering Group, Callaghan Innovation
Steve Tallon Team Leader, Process Engineering Group, Callaghan Innovation
13:00
Roundtables Session 1: Analysis and testing Bruce Fraser Team Leader, Process Engineering Group, Callaghan Innovation Sam Dallas Analytical Technology Technician, Hill Laboratories
Bruce Fraser Team Leader, Process Engineering Group, Callaghan Innovation
Sam Dallas Analytical Technology Technician, Hill Laboratories
13:40
Roundtables Session 2: Application process in obtaining a licence through the Medicinal Cannabis Agency – tips and tricks Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
13:40
Roundtables Session 2: EBM4CBD/THC Dr Afraz Adam MBBS. FRNZCUC Chief Medical Officer, CannaPlus+ Dr. Michael Murphy MB, BS, Pharm B.Sc (Hons) Clinical Director, CannaPlus+
Dr Afraz Adam MBBS. FRNZCUC Chief Medical Officer, CannaPlus+
Dr. Michael Murphy MB, BS, Pharm B.Sc (Hons) Clinical Director, CannaPlus+
13:40
Roundtables Session 2: Extraction technologies Steve Tallon Team Leader, Process Engineering Group, Callaghan Innovation
Steve Tallon Team Leader, Process Engineering Group, Callaghan Innovation
13:40
Roundtables Session 2: Analysis and testing Bruce Fraser Team Leader, Process Engineering Group, Callaghan Innovation Sam Dallas Analytical Technology Technician, Hill Laboratories
Bruce Fraser Team Leader, Process Engineering Group, Callaghan Innovation
Sam Dallas Analytical Technology Technician, Hill Laboratories
14:20
Plenary AFTERNOON BREAK
15:10
Plenary International Speaker – CBD: Past, Present & Future Martin A Lee Director, Project CBD
Martin A Lee Director, Project CBD